• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2024 Oct 9;24(1):1126.
doi: 10.1186/s12879-024-10059-y. Post-viral symptoms and conditions are more frequent in COVID-19 than influenza, but not more persistent

Falko Tesch[SUP] 1 [/SUP], Franz Ehm[SUP] 2 [/SUP], Friedrich Loser[SUP] 3 [/SUP], Lars Bechmann[SUP] 4 [/SUP], Annika Vivirito[SUP] 5 [/SUP], Danny Wende[SUP] 6 [/SUP], Manuel Batram[SUP] 7 [/SUP], Tilo Buschmann[SUP] 8 [/SUP], Simone Menzer[SUP] 4 [/SUP], Marion Ludwig[SUP] 5 [/SUP], Martin Roessler[SUP] 6 [/SUP], Martin Seifert[SUP] 2 [/SUP], Giselle Sarganas Margolis[SUP] 9 [/SUP], Lukas Reitzle[SUP] 9 [/SUP], Christina König[SUP] 3 [/SUP], Claudia Schulte[SUP] 6 [/SUP], Dagmar Hertle[SUP] 6 [/SUP], Pedro Ballesteros[SUP] 6 [/SUP], Stefan Baßler[SUP] 8 [/SUP], Barbara Bertele[SUP] 3 [/SUP], Thomas Bitterer[SUP] 4 [/SUP], Cordula Riederer[SUP] 10 [/SUP], Franziska Sobik[SUP] 10 [/SUP], Christa Scheidt-Nave[SUP] 9 [/SUP], Jochen Schmitt[SUP] 2 [/SUP]



Affiliations
Free article Abstract

Background: Post-viral symptoms have long been known in the medical community but have received more public attention during the COVID-19 pandemic. Many post-viral symptoms were reported as particularly frequent after SARS-CoV-2 infection. However, there is still a lack of evidence regarding the specificity, frequency and persistence of these symptoms in comparison to other viral infectious diseases such as influenza.
Methods: We investigated a large population-based cohort based on German routine healthcare data. We matched 573,791 individuals with a PCR-test confirmed SARS-CoV-2 infection from the year 2020 to contemporary controls without SARS-CoV-2 infection and controls from the last influenza outbreak in 2018 and followed them up to 18 months.
Results: We found that post-viral symptoms as defined for COVID-19 by the WHO as well as tissue damage were more frequent among the COVID-19 cohort than the influenza or contemporary control cohort. The persistence of post-viral symptoms was similar between COVID-19 and influenza.
Conclusion: Post-viral symptoms following SARS-CoV-2 infection constitute a substantial disease burden as they are frequent and often persist for many months. As COVID-19 is becoming endemic, the disease must not be trivialized. Research should focus on the development of effective treatments for post-viral symptoms.

Keywords: Claims data; Cohort study; Influenza; Post-COVID; SARS-CoV-2.

 
Back
Top Bottom